Boxer Capital Management, LLC

Position in SRZN — Surrozen, Inc./DE

CIK 2018299 San Diego, CA

Position in SRZN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$28,692,473

+$6,369,630 QoQ

Shares Held

1,172,349

+40.7% QoQ

Ownership

9.97%

of shares outstanding

% of Portfolio

2.17%

of 13F equity value

Holder Rank

of 70 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Boxer Capital Management, LLC holds $1,304,041,012 across 59 Biotechnology names. SRZN ranks #14 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TNGX	Tango Therapeutics, Inc.	10,876,219	$339,990,605
2	RVMD	Revolution Medicines, Inc.	500,000	$93,640,000
3	ABVX	Abivax S.A.	605,000	$80,622,300
4	QURE	uniQure N.V.	1,503,300	$69,241,998
5	KOD	Kodiak Sciences Inc.	1,477,600	$57,567,296
6	KYMR	Kymera Therapeutics, Inc.	429,100	$49,204,897
7	DFTX	Definium Therapeutics, Inc.	998,500	$46,969,440
8	REPL	Replimune Group, Inc.	3,983,000	$44,091,810

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30 SRZNW	—	66,666	0.0%	Shares	Sole	2026-08-14
2026-06-30	$28,692,473	1,105,683	+44.3%	Shares	Sole	2026-08-14
2026-06-30	$26,962,491	1,039,017	+35.6%	Shares	Sole	2026-08-14
2026-03-31 SRZNW	—	66,666	0.0%	Shares	Sole	2026-05-15
2026-03-31	$22,322,843	766,318	—	Shares	Sole	2026-05-15
2026-03-31	$22,322,843	766,318	+84.1%	Shares	Sole	2026-05-15
2025-12-31 SRZNW	—	66,666	0.0%	Shares	Sole	2026-02-17
2025-12-31	$9,404,990	416,150	—	Shares	Sole	2026-02-17
2025-09-30 SRZNW	—	66,666	0.0%	Shares	Sole	2026-02-17
2025-06-30 SRZNW	—	66,666	0.0%	Shares	Sole	2026-02-17
2025-03-31 SRZNW	—	66,666	0.0%	Shares	Sole	2026-02-17
2024-12-31 SRZNW	—	66,666	—	Shares	Other	2025-02-14
No filing history on record for this holder in this stock.